Aberdeen Asset Management PLC UK reduced its position in shares of CVS Health Corporation (NYSE:CVS) by 11.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,590,995 shares of the pharmacy operator’s stock after selling 610,541 shares during the period. CVS Health Corporation accounts for about 1.3% of Aberdeen Asset Management PLC UK’s investment portfolio, making the stock its 18th largest position. Aberdeen Asset Management PLC UK’s holdings in CVS Health Corporation were worth $360,395,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CVS. Macquarie Group Ltd. boosted its position in shares of CVS Health Corporation by 16.6% in the fourth quarter. Macquarie Group Ltd. now owns 9,526,280 shares of the pharmacy operator’s stock worth $751,719,000 after buying an additional 1,359,100 shares during the last quarter. Pioneer Investment Management Inc. boosted its position in shares of CVS Health Corporation by 4.6% in the first quarter. Pioneer Investment Management Inc. now owns 8,033,087 shares of the pharmacy operator’s stock worth $630,598,000 after buying an additional 353,621 shares during the last quarter. Parnassus Investments CA boosted its position in shares of CVS Health Corporation by 2.9% in the first quarter. Parnassus Investments CA now owns 6,237,016 shares of the pharmacy operator’s stock worth $473,605,000 after buying an additional 175,695 shares during the last quarter. Bank of Montreal Can boosted its position in shares of CVS Health Corporation by 10.7% in the first quarter. Bank of Montreal Can now owns 4,939,142 shares of the pharmacy operator’s stock worth $387,722,000 after buying an additional 475,722 shares during the last quarter. Finally, LSV Asset Management boosted its position in shares of CVS Health Corporation by 44.2% in the first quarter. LSV Asset Management now owns 4,579,916 shares of the pharmacy operator’s stock worth $359,523,000 after buying an additional 1,404,384 shares during the last quarter. Institutional investors own 81.92% of the company’s stock.

Shares of CVS Health Corporation (NYSE:CVS) opened at 77.97 on Monday. The company has a market cap of $79.44 billion, a price-to-earnings ratio of 16.26 and a beta of 0.91. The company has a 50 day moving average price of $78.75 and a 200 day moving average price of $79.09. CVS Health Corporation has a one year low of $69.30 and a one year high of $98.44.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 3rd. Stockholders of record on Monday, July 24th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Thursday, July 20th. This represents a $2.00 annualized dividend and a dividend yield of 2.57%. CVS Health Corporation’s dividend payout ratio is presently 41.67%.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/08/07/cvs-health-corporation-nysecvs-shares-sold-by-aberdeen-asset-management-plc-uk.html.

A number of research analysts have issued reports on CVS shares. Jefferies Group LLC reiterated a “hold” rating and set a $82.00 price objective on shares of CVS Health Corporation in a research note on Friday, June 9th. Vetr upgraded CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $87.97 price objective for the company in a research note on Wednesday, May 24th. Evercore ISI reiterated an “outperform” rating and set a $88.00 price objective (up previously from $87.00) on shares of CVS Health Corporation in a research note on Wednesday, May 3rd. Cowen and Company reiterated an “outperform” rating and set a $86.00 price objective on shares of CVS Health Corporation in a research note on Tuesday, June 13th. Finally, Tigress Financial started coverage on CVS Health Corporation in a research note on Thursday, April 27th. They set a “buy” rating for the company. Nine investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $92.20.

In related news, CFO David M. Denton sold 230,510 shares of the firm’s stock in a transaction on Monday, June 12th. The stock was sold at an average price of $80.00, for a total value of $18,440,800.00. Following the completion of the transaction, the chief financial officer now owns 176,983 shares in the company, valued at approximately $14,158,640. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Helena Foulkes sold 20,332 shares of the firm’s stock in a transaction on Monday, June 19th. The stock was sold at an average price of $76.98, for a total value of $1,565,157.36. Following the completion of the transaction, the executive vice president now owns 59,300 shares of the company’s stock, valued at approximately $4,564,914. The disclosure for this sale can be found here. In the last quarter, insiders have sold 271,175 shares of company stock valued at $21,632,597. Company insiders own 0.61% of the company’s stock.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.